GigaCloud Announces Changes to its Board of Directors

GigaCloud Announces Changes to its Board of Directors

HONG KONG, Feb. 27, 2023 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B......

Fanhua to Announce Fourth Quarter and Fiscal Year 2022

Fanhua to Announce Fourth Quarter and Fiscal Year 2022

GUANGZHOU, China, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Fanhua Inc. (“Fanhua” or “the Company”) (Nasdaq: FANH), a leading independent financial services......

360 DigiTech to Announce Fourth Quarter and Full Year 2022

360 DigiTech to Announce Fourth Quarter and Full Year 2022

SHANGHAI, China, Feb. 27, 2023 (GLOBE NEWSWIRE) -- 360 DigiTech, Inc. (NASDAQ: QFIN) ("360 DigiTech" or the "Company"), a leading Credit-Tech platform in......

Celldex Therapeutics Presents Positive Data from

Celldex Therapeutics Presents Positive Data from

- Rapid, profound and durable responses across multiple dosing groups with favorable safety profile observed—positioning barzolimab as a potential......

Pineapple Energy to Ring Nasdaq Stock Market Closing Bell

Pineapple Energy to Ring Nasdaq Stock Market Closing Bell

Bell-ringing will mark near one-year anniversary of the Company’s listing as PEGY on NASDAQ MINNETONKA, Minn., Feb. 24, 2023 (GLOBE NEWSWIRE) --......

COMPASS Pathways plc to announce fourth quarter and

COMPASS Pathways plc to announce fourth quarter and

Conference call to be held at 8:00am ET (1:00pm UK)......

Melco Announces Earnings Release Date

Melco Announces Earnings Release Date

MACAU, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Melco Resorts & Entertainment Limited (Nasdaq: MLCO), a developer, owner and operator of integrated resort......

Zevra Therapeutics Announces Arimoclomol Research Featured

Zevra Therapeutics Announces Arimoclomol Research Featured

Interim data analysis of four-year, open-label extension from Phase 2/3 clinical trial suggests arimoclomol may reduce long-term progression of......

Pharvaris to Highlight Positive Phase 2 Data from RAPIDe-1

Pharvaris to Highlight Positive Phase 2 Data from RAPIDe-1

ZUG, Switzerland, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor......

Chindata Group to Release Fourth Quarter and Full Year 2022

Chindata Group to Release Fourth Quarter and Full Year 2022

BEIJING, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Chindata Group Holdings Limited (“Chindata Group” or the “Company”) (Nasdaq: CD), a leading carrier-neutral......

  • 1
  • ...
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • ...
  • 45
  • menu
    menu